Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database

Objective Multiple linear regression (MLR) and machine learning techniques in pharmacogenetic algorithm-based warfarin dosing have been reported. However, performances of these algorithms in racially diverse group have never been objectively evaluated and compared. In this literature-based study, we compared the performances of eight machine learning techniques with those of MLR in a large, racially-diverse cohort. Methods MLR, artificial neural network (ANN), regression tree (RT), multivariate adaptive regression splines (MARS), boosted regression tree (BRT), support vector regression (SVR), random forest regression (RFR), lasso regression (LAR) and Bayesian additive regression trees (BART) were applied in warfarin dose algorithms in a cohort from the International Warfarin Pharmacogenetics Consortium database. Covariates obtained by stepwise regression from 80% of randomly selected patients were used to develop algorithms. To compare the performances of these algorithms, the mean percentage of patients whose predicted dose fell within 20% of the actual dose (mean percentage within 20%) and the mean absolute error (MAE) were calculated in the remaining 20% of patients. The performances of these techniques in different races, as well as the dose ranges of therapeutic warfarin were compared. Robust results were obtained after 100 rounds of resampling. Results BART, MARS and SVR were statistically indistinguishable and significantly out performed all the other approaches in the whole cohort (MAE: 8.84–8.96 mg/week, mean percentage within 20%: 45.88%–46.35%). In the White population, MARS and BART showed higher mean percentage within 20% and lower mean MAE than those of MLR (all p values < 0.05). In the Asian population, SVR, BART, MARS and LAR performed the same as MLR. MLR and LAR optimally performed among the Black population. When patients were grouped in terms of warfarin dose range, all machine learning techniques except ANN and LAR showed significantly higher mean percentage within 20%, and lower MAE (all p values < 0.05) than MLR in the low- and high- dose ranges. Conclusion Overall, machine learning-based techniques, BART, MARS and SVR performed superior than MLR in warfarin pharmacogenetic dosing. Differences of algorithms’ performances exist among the races. Moreover, machine learning-based algorithms tended to perform better in the low- and high- dose ranges than MLR.

[1]  Xiang-min Xu,et al.  Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients , 2009, Pharmacogenetics and genomics.

[2]  Soo-Youn Lee,et al.  Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. , 2011, Clinical therapeutics.

[3]  M. Rieder,et al.  Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin , 2008, Clinical pharmacology and therapeutics.

[4]  P. Deloukas,et al.  Association of warfarin dose with genes involved in its action and metabolism , 2006, Human Genetics.

[5]  M. Waye,et al.  Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients , 2010, Journal of Thrombosis and Thrombolysis.

[6]  S. le Cessie,et al.  Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data. , 2011, European heart journal.

[7]  M-T M Lee,et al.  Prospective Study of Warfarin Dosage Requirements Based on CYP2C9 and VKORC1 Genotypes , 2008, Clinical pharmacology and therapeutics.

[8]  R. Altman,et al.  Estimation of the warfarin dose with clinical and pharmacogenetic data. , 2009, The New England journal of medicine.

[9]  J. Hirsh,et al.  Interactions of Warfarin with Drugs and Food , 1994, Annals of Internal Medicine.

[10]  Ethem Alpaydin,et al.  Introduction to Machine Learning (Adaptive Computation and Machine Learning) , 2004 .

[11]  K E Liu,et al.  Improvement of Adequate Use of Warfarin for the Elderly Using Decision Tree-based Approaches , 2013, Methods of Information in Medicine.

[12]  Ling-Zhi Wang,et al.  A warfarin‐dosing model in Asians that uses single‐nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9 , 2006, Clinical pharmacology and therapeutics.

[13]  David J. C. MacKay,et al.  Information Theory, Inference, and Learning Algorithms , 2004, IEEE Transactions on Information Theory.

[14]  B. Horne,et al.  Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation , 2007, Circulation.

[15]  Christine W. Duarte,et al.  High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans , 2011, Bioinform..

[16]  D. Hunter Gene–environment interactions in human diseases , 2005, Nature Reviews Genetics.

[17]  Panos Deloukas,et al.  The largest prospective warfarin-treated cohort supports genetic forecasting. , 2009, Blood.

[18]  C. Ugrinowitsch,et al.  Limitations of ordinary least squares models in analyzing repeated measures data. , 2004, Medicine and science in sports and exercise.

[19]  F. Kamali,et al.  VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. , 2012, Blood.

[20]  Munir Pirmohamed,et al.  Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. , 2010, Blood.

[21]  R. Habib,et al.  Improved accuracy of anticoagulant dose prediction using a pharmacogenetic and artificial neural network-based method , 2014, European Journal of Clinical Pharmacology.

[22]  H. Zhou,et al.  Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement. , 2012, Die Pharmazie.

[23]  Wei Zhang,et al.  Effect of CYP2C9–VKORC1 interaction on warfarin stable dosage and its predictive algorithm , 2015, Journal of clinical pharmacology.

[24]  Maria G. Frank Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults , 2008 .

[25]  Eun-Young Kim,et al.  Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement , 2009, Pharmacogenetics and genomics.

[26]  A. Egberts,et al.  VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement , 2007, Clinical pharmacology and therapeutics.

[27]  Massimo Buscema,et al.  Prediction of optimal warfarin maintenance dose using advanced artificial neural networks. , 2014, Pharmacogenomics.

[28]  R. Tibshirani,et al.  An introduction to the bootstrap , 1993 .

[29]  Deborah A Nickerson,et al.  Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. , 2005, The New England journal of medicine.

[30]  Wei Zhang,et al.  Comparison of the predictive abilities of pharmacogenetics-based warfarin dosing algorithms using seven mathematical models in Chinese patients. , 2015, Pharmacogenomics.

[31]  C. Richards,et al.  Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults , 2007, Annals of Internal Medicine.

[32]  Zhenya Shen,et al.  Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients , 2007, European Journal of Clinical Pharmacology.

[33]  F. Kamali,et al.  Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin , 2004, Clinical pharmacology and therapeutics.

[34]  Yusheng Zhu,et al.  Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes. , 2007, Clinical chemistry.

[35]  M. Gordon,et al.  Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data , 2009 .